Literature DB >> 27992901

Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient With Advanced Non-Small Cell Lung Cancer: A Case Report.

Konstantinos Syrigos1, Sofia Tsagouli1, Dimitra Grapsa1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27992901     DOI: 10.7326/L16-0137

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  6 in total

1.  Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient with Metastatic Gastric Adenocarcinoma.

Authors:  Masataka Nishikawa; Atsushi Goshima; Hajime Owaki; Takeshi Fuji
Journal:  Clin Drug Investig       Date:  2019-12       Impact factor: 2.859

Review 2.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

3.  Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review.

Authors:  Ammar Haikal; E Borba; Taqui Khaja; Gary Doolittle; Paul Schmidt
Journal:  Avicenna J Med       Date:  2018 Jan-Mar

Review 4.  Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature.

Authors:  Devis Benfaremo; Lucia Manfredi; Michele Maria Luchetti; Armando Gabrielli
Journal:  Curr Drug Saf       Date:  2018

5.  Ultrasound-Proven Severe Synovitis Induced by PD-1 Inhibitor Therapy in a Patient Predisposed to Seronegative Inflammatory Arthritis.

Authors:  Shin-Ya Kawashiri; Naoki Iwamoto; Kojiro Ohba; Atsushi Kawakami
Journal:  Case Rep Rheumatol       Date:  2019-07-24

6.  A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature.

Authors:  Bicky Thapa; Asad Ali; Raunak Nair; Rishik Vashisht; Cassandra Calabrese
Journal:  Case Rep Rheumatol       Date:  2019-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.